NPI: 1740239557 · BARRON, WI 54812 · Pharmacy · NPI assigned 05/09/2006
Authorized official BORTNEM, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | BORTNEM, MARK (CFO) |
| NPI Enumeration Date | 05/09/2006 |
Other providers sharing the same authorized official: BORTNEM, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,109 | $682K |
| 2019 | 34,661 | $845K |
| 2020 | 30,242 | $970K |
| 2021 | 39,366 | $1.22M |
| 2022 | 38,724 | $1.46M |
| 2023 | 40,964 | $1.28M |
| 2024 | 35,780 | $1.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,957 | 6,387 | $1.41M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8,639 | 5,687 | $1.07M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,763 | 2,329 | $1.06M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,639 | 5,446 | $928K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 21,412 | 15,472 | $490K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,108 | 1,861 | $380K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,359 | 1,200 | $325K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,588 | 1,399 | $305K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,745 | 1,255 | $258K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13,761 | 9,443 | $145K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 570 | 511 | $124K |
| 87631 | 1,336 | 1,235 | $105K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9,445 | 6,532 | $86K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 907 | 741 | $85K |
| 80053 | Comprehensive metabolic panel | 10,340 | 8,655 | $69K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,247 | 13,908 | $67K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 974 | 867 | $64K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,956 | 1,779 | $61K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,544 | 5,064 | $55K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,209 | 7,104 | $41K |
| 11721 | 1,091 | 640 | $37K | |
| 99215 | Prolong outpt/office vis | 4,047 | 2,948 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,096 | 1,008 | $34K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,374 | 2,128 | $34K |
| 80061 | Lipid panel | 3,107 | 2,871 | $25K |
| 71046 | Radiologic examination, chest; 2 views | 2,423 | 2,139 | $25K |
| 73630 | 987 | 769 | $24K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,754 | 1,960 | $22K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 82 | 76 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,290 | 3,967 | $20K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 103 | 94 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 448 | 403 | $17K |
| 83605 | 2,792 | 2,386 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,085 | 2,518 | $14K |
| 84484 | 1,965 | 1,623 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 861 | 645 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 570 | 495 | $13K |
| 81025 | 1,785 | 1,576 | $12K | |
| 83880 | 1,176 | 1,027 | $11K | |
| 86140 | 3,752 | 3,232 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 67 | 60 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,899 | 2,986 | $10K |
| 83690 | 2,312 | 1,979 | $10K | |
| 81001 | 5,053 | 4,410 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 121 | 109 | $8K |
| 85610 | 7,104 | 4,105 | $8K | |
| 87480 | 526 | 484 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,962 | 4,179 | $8K |
| 87660 | 526 | 484 | $8K | |
| 87510 | 526 | 484 | $8K | |
| 73564 | 354 | 299 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 450 | 267 | $7K |
| 85027 | 1,864 | 1,590 | $7K | |
| 83735 | 2,405 | 2,016 | $7K | |
| 80050 | General health panel | 276 | 249 | $7K |
| 87103 | 916 | 806 | $7K | |
| 87040 | 1,711 | 806 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 434 | 410 | $6K |
| 80306 | 437 | 377 | $6K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 690 | 481 | $5K |
| 73030 | 239 | 204 | $5K | |
| 82570 | 1,426 | 1,237 | $4K | |
| 82043 | 1,182 | 1,071 | $4K | |
| 20610 | 55 | 29 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 16 | 14 | $4K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,208 | 549 | $4K |
| 71045 | Radiologic examination, chest; single view | 2,497 | 2,198 | $4K |
| 36415 | Collection of venous blood by venipuncture | 12,834 | 10,335 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,218 | 1,103 | $3K |
| 81003 | 2,179 | 1,994 | $3K | |
| 82565 | 1,270 | 1,092 | $3K | |
| 82077 | 335 | 283 | $3K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 206 | 139 | $3K |
| 85379 | 503 | 454 | $2K | |
| 86850 | 636 | 571 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 222 | 204 | $2K |
| 82947 | 810 | 600 | $2K | |
| 84702 | 168 | 120 | $2K | |
| 82248 | 873 | 738 | $2K | |
| 97162 | 253 | 239 | $2K | |
| 73502 | 77 | 71 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 709 | 624 | $2K |
| 76801 | 12 | 12 | $2K | |
| 87077 | 478 | 435 | $2K | |
| 73610 | 72 | 64 | $2K | |
| 84450 | 396 | 349 | $1K | |
| Q3014 | Telehealth originating site facility fee | 235 | 217 | $1K |
| 73110 | 50 | 37 | $1K | |
| 91322 | 180 | 172 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,824 | 2,273 | $1K |
| 72100 | 51 | 42 | $999.42 | |
| 99307 | 86 | 83 | $941.69 | |
| 90662 | 505 | 481 | $872.97 | |
| 87186 | 328 | 305 | $868.39 | |
| 90715 | 48 | 40 | $861.61 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 46 | 38 | $845.55 |
| 82948 | 254 | 142 | $788.03 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 562 | 517 | $780.77 |
| 82803 | 56 | 51 | $763.76 | |
| 86900 | 391 | 350 | $745.17 | |
| 86901 | 391 | 350 | $745.17 | |
| 99443 | 38 | 34 | $637.25 | |
| 76830 | Ultrasound, transvaginal | 12 | 12 | $613.30 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 116 | 48 | $585.19 |
| 99442 | 65 | 55 | $558.04 | |
| 84153 | 42 | 39 | $555.01 | |
| 90686 | 319 | 307 | $499.82 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 13 | 12 | $496.78 |
| 76376 | 12 | 12 | $479.58 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 24 | 24 | $478.56 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 115 | 93 | $434.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,432 | 1,931 | $425.09 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12 | 12 | $401.01 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12 | 12 | $401.01 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,831 | 1,490 | $341.03 |
| 36416 | 1,821 | 1,016 | $337.79 | |
| 80143 | 29 | 25 | $335.52 | |
| 85018 | 184 | 162 | $327.24 | |
| 90480 | 167 | 160 | $279.35 | |
| 88142 | 12 | 12 | $275.70 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 14 | 13 | $234.36 |
| 85652 | 137 | 123 | $220.56 | |
| 83655 | 14 | 12 | $181.17 | |
| 84439 | 32 | 30 | $161.82 | |
| 99441 | 26 | 26 | $150.98 | |
| 80179 | 14 | 13 | $139.44 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 261 | 239 | $108.97 |
| 84460 | 41 | 39 | $108.34 | |
| J2704 | Injection, propofol, 10 mg | 664 | 184 | $105.01 |
| J7030 | Infusion, normal saline solution , 1000 cc | 953 | 769 | $81.12 |
| 90656 | 48 | 48 | $67.90 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,733 | 1,304 | $53.54 |
| 0764T | 119 | 106 | $49.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,073 | 664 | $39.38 |
| J3490 | Unclassified drugs | 311 | 231 | $36.67 |
| J7050 | Infusion, normal saline solution, 250 cc | 619 | 368 | $36.42 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 209 | 189 | $34.68 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 39 | 26 | $31.29 |
| 87070 | 29 | 28 | $23.71 | |
| 90677 | 15 | 14 | $23.33 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 129 | 111 | $22.63 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 127 | 103 | $18.24 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 27 | 27 | $17.80 |
| 82728 | 28 | 26 | $14.08 | |
| 0124A | 52 | 51 | $10.72 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | 13 | $6.56 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 82 | 64 | $5.71 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 69 | 55 | $3.91 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 28 | 25 | $3.16 |
| 0004A | 46 | 43 | $2.27 | |
| 0134A | 19 | 19 | $2.02 | |
| 0054A | 51 | 45 | $1.11 | |
| 96376 | 73 | 61 | $0.24 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 89 | 78 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 43 | 37 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 29 | 15 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 17 | 13 | $0.00 |
| A9270 | Non-covered item or service | 1,791 | 1,568 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 25 | 13 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 631 | 621 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 18 | 14 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 18 | 13 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 16 | 12 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 17 | 15 | $0.00 |